Is there an increased risk of severe COVID-19 among patients with systemic lupus erythematosus treated with anifrolumab? - Sorbonne Université Access content directly
Journal Articles Lupus Year : 2023

Dates and versions

hal-04080166 , version 1 (03-07-2023)

Identifiers

Cite

Paul Breillat, Alexis Mathian, Flore Rozenberg, Amélie Dutheil, Annick Barbaud, et al.. Is there an increased risk of severe COVID-19 among patients with systemic lupus erythematosus treated with anifrolumab?. Lupus, 2023, 32 (3), pp.453-455. ⟨10.1177/09612033231153536⟩. ⟨hal-04080166⟩
3 View
9 Download

Altmetric

Share

Gmail Facebook X LinkedIn More